Volume 5 / Issue 510 / 201003 October 1, 2020 Neurology | Syncope Does the addition of N-terminal pro–B-type natriuretic peptide measurement to the Canadian Syncope Risk Score improve the prediction of 30-day serious adverse events in emergency department patients presenting with syncope? Charles S. Graffeo
